Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 5
Results: 15
Cancer immunotherapy in patients with brain metastases.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 703, doi. 10.1007/s00262-018-2146-8
- By:
- Publication type:
- Article
Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 843, doi. 10.1007/s00262-018-2141-0
- By:
- Publication type:
- Article
PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 805, doi. 10.1007/s00262-018-2138-8
- By:
- Publication type:
- Article
The Third Institute for Cancer Vaccines and Immunotherapy (ICVI) symposium on immunotherapy: May 12-13, 2017, Royal Society, London, UK.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 815, doi. 10.1007/s00262-018-2136-x
- By:
- Publication type:
- Article
Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 835, doi. 10.1007/s00262-018-2135-y
- By:
- Publication type:
- Article
Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 825, doi. 10.1007/s00262-018-2134-z
- By:
- Publication type:
- Article
Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 785, doi. 10.1007/s00262-018-2133-0
- By:
- Publication type:
- Article
TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 761, doi. 10.1007/s00262-018-2130-3
- By:
- Publication type:
- Article
The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 775, doi. 10.1007/s00262-018-2129-9
- By:
- Publication type:
- Article
Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 739, doi. 10.1007/s00262-018-2128-x
- By:
- Publication type:
- Article
Certain BCG-reactive responses are associated with bladder cancer prognosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 797, doi. 10.1007/s00262-018-2127-y
- By:
- Publication type:
- Article
Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 713, doi. 10.1007/s00262-018-2126-z
- By:
- Publication type:
- Article
Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 749, doi. 10.1007/s00262-018-2124-1
- By:
- Publication type:
- Article
Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 729, doi. 10.1007/s00262-018-2123-2
- By:
- Publication type:
- Article